Experimental Treatment Helps 2 Out of 3 Peanut Allergy Sufferers
An experimental new drug may now make it possible for some people with allergies to peanuts to build up a tolerance over time, saving countless lives. Could similar allergy-treatments be in the works for other major food allergens? [1]
The clinical trial, funded by Aimmune Therapeutics, included 551 participants ranging in age from 4 to 55 years who suffered from a peanut allergy. Most of the children involved were between the ages of 4 and 17.